Peptide shows potential in becoming next diabetes drug

09 Feb 2018


Catestatin treatment significantly improves glucose and insulin sensitivity in mice, a study in Diabetes reports. 

Science Daily


Related Topics

Endocrine-Disrupting Chemicals

Share this story